Clinical evaluation of teicoplanin fluorescence polarization immunoassay

Statistical Adjustment of Data

1944 • 810 citations

Fluorescence Polarization Immunoassay for the Determination of Therapeutic Drug Levels in Human Plasma

1981 • 199 citations

In vitro activity and human pharmacokinetics of teicoplanin

1984 • 152 citations

Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon

1991 • 112 citations

Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis

1990 • 98 citations

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria

1986 • 86 citations

Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections

1987 • 60 citations

Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis

1991 • 57 citations

HPLC quantitation of the six main components of teicoplanin in biological fluids

1988 • 28 citations

A sensitive bioassay for teicoplanin in serum in the presence or absence of other antibiotics

1989 • 27 citations

Determination of teicoplanin concentrations in serum by high-pressure liquid chromatography

1987 • 21 citations

Teicoplanin in the treatment of infection caused by Gram-positive organisms

1986 • 17 citations

Bioassay of teicoplanin in serum containing rifampin or a beta-lactam antibiotic

1989 • 3 citations